pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
TARA-002
Unspecified Rare Disease
$TARA
Protara Therapeutics, Inc.
0
catalysts
Phase 2
TAS-0728
Solid Tumor
Taiho Pharmaceutical Co Ltd
0
catalysts
Phase 2
TB-006
Alzheimer's Disease
TrueBinding Inc
0
catalysts
Phase 2
TBA-7371
Pulmonary Tuberculosis
← prev
page 27 of 50
next →
131
Pain
89
Neurology
1
Decaprenylphosphoryl-beta-D-ribose oxidase
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
TDM-105795
Androgenic Alopecia
Technoderma Medicines Inc
0
catalysts
Phase 2
TDM-180935
Atopic Dermatitis (Atopic Eczema)
Technoderma Medicines Inc
0
catalysts
Phase 2
TERN-501
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$TERN
Terns Pharmaceuticals, Inc.
0
catalysts
Phase 2
TERN-701
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$TERN
Terns Pharmaceuticals, Inc.
0
catalysts
Phase 2
TEV-408
Celiac Disease
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
0
catalysts
Phase 2
TG-01
Pancreatic Cancer
Prostaglandin G/H synthase 2
Circio Holding ASA
0
catalysts
Phase 2
TG-1042
Basal Cell Carcinoma (Basal Cell Epithelioma)
Stamford Pharmaceuticals Inc
0
catalysts
Phase 2
TG-4050
Myvac
Head And Neck Cancer
Transgene SA
0
catalysts
Phase 2
TH-103
Wet (Neovascular / Exudative) Macular Degeneration
$KLRS
Kalaris Therapeutics, Inc.
0
catalysts
Phase 2
TILT-123
Ovarian Cancer
TILT Biotherapeutics Ltd
0
catalysts
Phase 2
TLD-1433
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Theralase Technologies Inc
0
catalysts
Phase 2
TLL-018
Plaque Psoriasis (Psoriasis Vulgaris)
Hangzhou Highlightll Pharmaceutical Co Ltd
0
catalysts
Phase 2
TLP-02
Metablok
Acute Respiratory Distress Syndrome
Arch Biopartners Inc
0
catalysts
Phase 2
TLX-250
Metastatic Renal Cell Carcinoma
$TLX
Telix Pharmaceuticals Ltd
0
catalysts
Phase 2
TMB-365
Human Immunodeficiency Virus (HIV) Infections (AIDS)
TaiMed Biologics Inc
0
catalysts
Phase 2
TMB-365 + TMB-380
Human Immunodeficiency Virus (HIV) Infections (AIDS)
TaiMed Biologics Inc
0
catalysts
Phase 2
TN-201
Hypertrophic Cardiomyopathy
$TNYA
Tenaya Therapeutics, Inc.
0
catalysts
Phase 2
TN-401
Cardiomyopathy
$TNYA
Tenaya Therapeutics, Inc.
0
catalysts
Phase 2
TNG-260
Cervical Cancer
$TNGX
Tango Therapeutics, Inc.
0
catalysts
Phase 2
TNG-456
Bladder Cancer
$TNGX
Tango Therapeutics, Inc.
0
catalysts
Phase 2
TP-102
Diabetic Foot Ulcers
Lxbio Pharmaceuticals SA
0
catalysts
Phase 2
TPX-100
Osteoarthritis
OrthoTrophix Inc
0
catalysts
Phase 2
TRI-611
Non-Small Cell Lung Cancer
TRIANA Biomedicines Inc
0
catalysts
Phase 2
TRK-950
Adenocarcinoma Of The Gastroesophageal Junction
Toray Industries Inc
0
catalysts
Phase 2
TRN-261
Pain
Tris Pharma Inc
0
catalysts
Phase 2
TRX-103
Crohn's Disease (Regional Enteritis)
Tr1X Inc
0
catalysts